ObsEva (NASDAQ:OBSV) – After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its
After running into a major roadblock at the FDA for its uterine fibroid drug, ObsEva SA OBSV has flagged ...
Read moreAfter running into a major roadblock at the FDA for its uterine fibroid drug, ObsEva SA OBSV has flagged ...
Read moreGRAND RAPIDS, Mich. (WOOD) — The recently formed Beaumont Health and Spectrum Health system has announced ...
Read more2TM, the parent group of Mercado Bitcoin, announced the termination of 15% of its employees following ...
Read moreVisitors stands in front of an electronic ticker at the Tokyo Stock Exchange (TSE), operated by ...
Read moreChina cut its benchmark loan prime rate on Monday, a move that will provide more support ...
Read moreFuture Financial Wealth Managment LLC reduced its position in shares of Apple Inc. (NASDAQ:AAPL – Get ...
Read moreSteph Kukuljan , Annika Merrilees CLAYTON — For decades, managed health care company Centene Corp. focused ...
Read moreBERLIN—Lights illuminating many of the German capital’s monuments are going dark. Officials here and in the ...
Read moreAdvisor Group Holdings Inc. cut its holdings in Arrow Dow Jones Global Yield ETF (NYSEARCA:GYLD – ...
Read morePeople wait in line for T-shirts at a pop-up kiosk for the online brokerage Robinhood in ...
Read more© 2022 TheDailyStock.News